Join to view full profile
9500 Euclid AveCleveland, OH 44195
Phone+1 800-223-2273
Join Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 5 invites waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Melissa Piliang, MD is a board certified dermatologist in Cleveland, Ohio. She is currently licensed to practice medicine in Ohio, Florida, and Indiana. She is affiliated with Cleveland Clinic Hillcrest Hospital.
Education & Training
Cleveland Clinic FoundationFellowship, Dermatopathology, 2005 - 2006- Cleveland Clinic FoundationResidency, Dermatology, 2001 - 2005
Indiana University School of MedicineClass of 2001
Certifications & Licensure
OH State Medical License 2006 - 2028
FL State Medical License 2015 - 2027
IN State Medical License 2008 - 2027- OH State Medical License 2001 - 2026
American Board of Dermatology Dermatology- American Board of Dermatology Dermatopathology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2012, 2014-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2012, 2014-2017
Publications & Presentations
PubMed
- 1 citationsFrequency of androgenic cutaneous adverse events associated with levonorgestrel intrauterine devices: An analysis of the Food and Drug Administration Adverse Event Rep...Lydia Cassard, Jameson Mitchell, Melissa Piliang
Journal of the American Academy of Dermatology. 2025-03-01 - 10 citationsSustained hair regrowth with continued ritlecitinib treatment through week 48 in patients with alopecia areata with or without early target responses: Post hoc analysi...Melissa Piliang, Charles Lynde, Brett King, Paradi Mirmirani, Rodney Sinclair
Journal of the American Academy of Dermatology. 2025-02-01 - 28 citationsEfficacy and safety of the oral Janus kinase 3/tyrosine kinase expressed in hepatocellular carcinoma family kinase inhibitor ritlecitinib over 24 months: integrated an...Melissa Piliang, Jennifer Soung, Brett King, Jerry Shapiro, Lidia Rudnicka
The British Journal of Dermatology. 2025-01-24
Press Mentions
Responses Sustained with Ritlecitinib in Patients with Alopecia Through 48 WeeksOctober 22nd, 2024- Study Finds That Nail Salon UV Lamps Could Increase Cancer RiskJanuary 23rd, 2023
- Getting Your Nails Done Frequently Could Damage the DNA in Your HandsJanuary 19th, 2023